Geode Capital Management’s Syneron Medical Ltd ELOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-16,633
Closed -$182K 4131
2017
Q2
$182K Sell
16,633
-1,625
-9% -$17.8K ﹤0.01% 3721
2017
Q1
$192K Sell
18,258
-25,588
-58% -$247K ﹤0.01% 3668
2016
Q4
$367K Buy
43,846
+15,159
+53% +$119K ﹤0.01% 3387
2016
Q3
$204K Buy
28,687
+7,730
+37% +$53.7K ﹤0.01% 3596
2016
Q2
$161K Sell
20,957
-53
-0.3% -$378 ﹤0.01% 3662
2016
Q1
$152 Buy
21,010
+1,159
+6% +$8.3K ﹤0.01% 3712
2015
Q4
$152K Sell
19,851
-175
-0.9% -$1.33K ﹤0.01% 3774
2015
Q3
$142K Buy
20,026
+8,661
+76% +$83.2K ﹤0.01% 3796
2015
Q2
$120K Buy
11,365
+87
+0.8% +$1.02K ﹤0.01% 3732
2015
Q1
$139K Buy
11,278
+245
+2% +$2.71K ﹤0.01% 3680
2014
Q4
$102K Buy
+11,033
New +$106K ﹤0.01% 3782

Other funds holding ELOS

Geode Capital Management's ELOS Position: Q3 2017 in Review

Geode Capital Management sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 16,633 shares — an estimated $182K sold.

Geode Capital Management first reported a position in ELOS in Q4 2014 and held it in 11 quarters. The position peaked at $367K in Q4 2016. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Geode Capital Management reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Geode Capital Management sold 16,633 Syneron Medical Ltd shares in Q3 2017, an estimated $182K.
  • Geode Capital Management first reported a position in Syneron Medical Ltd in Q4 2014 and held it in 11 quarters.
  • Geode Capital Management's Syneron Medical Ltd position peaked at $367K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Geode Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.